Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fisetin for COVID-19 in nursing home residents
NCT04537299Phase 2Terminated
- Sponsor
- Mayo Clinic
- Start
- Apr 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fisetin in coronavirus disease 2019 (COVID-19), sponsored by Mayo Clinic. Started Apr 2022; status: terminated.
02
Drugs
fisetin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04537299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04537299.